ArticleCureus2025
Brittle Diabetes Following Partial Pancreatectomy: A Case of Type 3c Diabetes Mellitus Complicated by Type 4 Renal Tubular Acidosis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Type 3c diabetes mellitus (T3cDM), or pancreatogenic diabetes, is an under-recognized subtype of diabetes resulting from exocrine pancreatic disease or surgery. It is frequently misclassified as type 1 or type 2 diabetes, leading to inappropriate management. Brittle diabetes, characterized by severe glycemic variability and insulin sensitivity, is rare in T3cDM. Type 4 renal tubular acidosis (RTA), or hyperkalemic distal RTA, is another underdiagnosed complication of diabetic kidney disease. We report a unique case of transition to T3cDM presenting as brittle diabetes in a patient with a history of partial pancreatectomy, complicated by type 4 RTA. This case highlights the clinical challenge of managing brittle diabetes in the context of T3cDM, a condition that often goes unrecognized in patients with a history of pancreatic surgery. The concurrent diagnosis of type 4 RTA complicated glucose and electrolyte management, as insulin is both therapeutic for hyperkalemia and a risk for hypoglycemia in brittle diabetes. Awareness of this overlap is essential, as both conditions require individualized therapy that departs from traditional inpatient diabetes management. Clinicians should maintain a high index of suspicion for T3cDM in patients with pancreatic pathology and unstable glycemic profiles. Accurate diagnosis is key to appropriate treatment and prevention of complications. Additionally, type 4 RTA should be considered in diabetics with unexplained hyperkalemia despite preserved renal function. A multidisciplinary approach is essential for managing the complex interplay between glucose and potassium regulation in such patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.